EARLY CASE OF RESISTANCE TO NEW ANTIBIOTIC (p 207)July 18, 2001A fast-track research letter published in this week’s issue of THE LANCET describes the case of a patient whose infecting bacterium developed resistance to one of the new so-called bug-busting antibiotics. Multidrug resistant bacteria have caused enormous difficulties worldwide over the past few decades. Scientists had hoped, however, that new drugs currently available for prescription would help to suppress the emergence of superbugs such as meticillin-resistant Staphylococcus aureus (MRSA) that created media headlines last year. The new antibiotic linezolid has been approved for the treatment of infections caused by various gram-positive bacteria, including MRSA and vancomycin-resistant enterococci (VRE). Although instances of linezolid resistance in VRE have been previously reported (Lancet 2001; 357: 1179), resistance has not been encountered among clinical isolates of S. aureus. Mary Jane Ferraro from Massachusetts General Hospital, Boston, USA, identified an MRSA isolate resistant to linezolid that was recovered from an 85-year-old patient treated for dialysis-associated peritonitis. Co-investigators at Beth Israel Deaconess Medical Center, Boston, USA, have characterised the isolate and determined its mechanism of resistance to linezolid. Mary Jane Ferraro comments: “This is an important finding because up to now the only other isolate of Staphylococcus aureus that was resistant to linezolid was produced in the laboratory. Unlike previous clinical isolates of linezolid-resistant enterococci, this high-level resistance has occurred in S aureus, which is much more virulent. Clinicians should not assume that all S aureus isolates are susceptible to linezolid, but it highlights the need for clinical laboratories to perform susceptibility tests on new antibiotics being used for patients in their hospital.” Howard Gold, a member of the team at Beth Israel Deaconess that characterised the isolate, adds: “The finding of this resistant isolate must be put in perspective. So far this appears to be a very rare event, but the drug has only been widely used in the USA during the past year. There is no evidence of further spread or other occurrences of this organism. The finding of occasional resistance should not diminish the importance of new antibiotics like linezolid that are active against multiresistant bacteria like MRSA.” Contact: Dr Howard Gold, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA USA, T) +1 617 632 0760; F) +1 617 975 5235, E) hogold@caregroup.harvard.edu Dr Mary Jane Ferraro, Clinical Microbiology Laboratories, Massachusetts General Hospital, Gray B-526, Boston, MA 02114, USA; T) +1 617 726 3612; F) +1 617 726 5957; E) ferraro.maryjane@mgh.harvard.edu | |||||||||||||||||||||
|
Related Bacteria News Articles University of Virginia Study Reveals Promising Method for Reducing MRSA Infections in Hospital Intensive Care Units Doctors at the University of Virginia Health System have significantly reduced MRSA infections among surgical intensive care patients by using antibiotic cycling, a method of rotating drugs at regular intervals. Atomic structure of the mammalian 'fatty acid factory' determined Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. Bad sign for global warming: Thawing permafrost holds vast carbon pool Permafrost blanketing the northern hemisphere contains more than twice the amount of carbon in the atmosphere, making it a potentially mammoth contributor to global climate change depending on how quickly it thaws. 'Superbug' breast infections controllable in nursing mothers, researchers find Many nursing mothers who have been hospitalized for breast abscesses are afflicted with the "superbug" methicillin-resistant Staphylococcus aureus, or MRSA, but according to new research by UT Southwestern Medical Center physicians, conservative treatment can deal with the problem. Arteries from distinct regions of the body have unique immune functions Human arteries play distinct roles in the immune system depending on their anatomical location, researchers at Emory University School of Medicine have discovered. New research challenges long-held assumptions of flightless bird evolution Large flightless birds of the southern continents - African ostriches, Australian emus and cassowaries, South American rheas and the New Zealand kiwi - do not share a common flightless ancestor as once believed. Nature inspires new highly specific drugs and organic products The best place to seek novel compounds for pharmaceutical drugs, alternative energy sources, and a host of industrial applications, is within natural systems that have evolved over millions of years. Innate immune system targets asthma-linked fungus for destruction A new study shows that the innate immune system of humans is capable of killing a fungus linked to airway inflammation, chronic rhinosinusitis and bronchial asthma. Scientists develop new method to investigate origin of life Scientists at Penn State have developed a new computational method that they say will help them to understand how life began on Earth. Stick with simple antibiotics for pneumonia to avoid super bugs, says researcher Australian hospitals should avoid prescribing expensive broad-spectrum antibiotics for pneumonia to avoid the development of more drug-resistant super bugs, according to a University of Melbourne study. More Bacteria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||